The use of retinyl palmitate (RP) as an oral positive control agent was dem
onstrated in CD rats and New Zealand White rabbits in 3 developmental toxic
ity studies in each species. Based on dose range-finding studies 1000 or 30
0 mg/kg day(-1) (i.e., 250,000 and 75,000 IU/kg day(-1)) were administered
by oral gavage to rats and rabbits, respectively on gestation days (GD) 9 a
nd 10. The vehicle control groups received either 1% methylcellulose/0.2% T
ween 80 or deionized distilled water from GD 6 to 15 in rats and from GD 6
to 18 in rabbits. Maternal clinical signs, body weights, and food consumpti
on were evaluated. Necropsy and cesarean-section observations were conducte
d on GD 20 and 29 in rats and rabbits, respectively All viable fetuses were
weighed, sexed, and externally examined. In rats but not rabbits, maternal
toxicity was observed as significantly decreased body weights and food con
sumption, while fetal toxicity occurred as significantly decreased fetal bo
dy weights. RP was teratogenic in both rats and rabbits, producing a spectr
um of significantly increased external, skeletal, and visceral fetal anomal
ies in all RP-treated groups. The observed malformations were typical of th
ose produced by vitamin A, i.e., cleft palate, pinna anomalies, and microph
thalmia/anophthalmia. These studies demonstrate that RP is a reproducible a
nd cost-effective positive control agent for use in rat and rabbit developm
ental toxicity studies.